FDA Globalization Capacity, Shortage Monitoring Remain Concerns, GAO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
In updated high-risk report, GAO says resources are an issue for FDA’s globalization plans and the agency should better manage its drug shortage data.